ABX is the leading manufacturer of high-quality radiopharmaceutical products for molecular imaging & therapy mainly used for the the detection of tumors by PET and SPECT.
Our company develops, produces, tests and markets precursors/active ingredients, reagent kits and hardware cassettes.
An excerpt from our portfolio:
- F-PSMA-1007 precursor, reagents & cassettes for GE, ORA Neptis, IBA Synthera, Synthra & Trasis AIO modules
- Stable supply of GMP-grade O-18 Water
- FDG reagent kits & cassettes for nearly all FDG modules incl. Mannose Triflate and Cryptand222
- Peptides e.g. PSMA-11, DOTA-TOC, DOTA-TATE & DOTA-NOC for Gallium68 labelling
- Nucleophilic & electrophilic F-DOPA, FLT, F-Choline, F-MISO, FET & NAF precursors, reagents & cassettes
- Gallium-68 and Lutetium-177 reagents kits & cassettes
- SPECT precursors e. g. CuMIBI, MIBG, ECD
- Custom syntheses according to Q7 chapter 19 for clinical PET studies (APIs)
- Performance of stability studies
- Development of radiotracers & labelling as well as purification strategies
Our laboratories and clean rooms are GMP certified and meet pharmaceutical standards. We are GMP and ISO13485 certified with a team highly experienced in GMP production.